Clinical – media

mHealth app for clinical decision support improves diagnosis time, test ordering

Mobile health (mHealth) applications for clinical decision support could improve physicians’ test ordering and diagnosis decisions, according to a study published April 20 in the Journal of Informatics in Health and Biomedicine.
- Source: Clinical Innovation
- 630
- April 27, 2018
Clinical mHealth Researches
GE Healthcare and Roche join forces to create clinical decision support tools

GE Healthcare and Roche have launched a partnership to assist clinicians in making better choices and help patients get individualized care.
- Source: MedCityNews
- 580
- January 12, 2018
Clinical Company Insight Roche
Clinicians still struggle to quickly access EHRs at point of care

Computers and workstations on wheels (WoWs) were designed to help clinicians spend less time working from nursing-station desktops and more time at the point of care. The reality, however, is that the ideal has yet to be fully realized. All too often care team workflows remain fragmented because of the need to access patient data and clinical information from multiple disparate systems.
- Source: healthcareitnews
- 476
- December 25, 2017
Clinical EHR Researches WoWs
Here’s where ‘Smart Hospitals’ will make big tech investments in the near future

Most U.S. hospitals have a broad portfolio of digital technologies already in place and other innovations in early development or deployment stages, but far fewer qualify as so-called smart hospitals.
- Source: healthcareitnews
- 549
- December 15, 2017
Clinical digital Market Views
Wearable Devices–A New Look For The Modern Clinical Trial

Clinical development has historically been a laborious and expensive process that stretches across all therapeutic areas. It is driven by lengthy patient recruitment timelines, increasingly complex study designs, and high procedural costs. Depending on whose data you believe, getting a new drug to market can now cost upwards of $1 billion and take more than 10 years or research and development effort. Additionally, a complex and dynamic regulatory framework has made sponsors reluctant to introduce new technologies to facilitate the development process.
- Source: clinicalleader
- 988
- November 2, 2017
Artificial Intelligence Clinical machine learning Researches wearables
FDA awards 15 grants for clinical trials to stimulate product development for rare diseases

The U.S. Food and Drug Administration(FDA) announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country.
- Source: fda.gov
- 619
- October 9, 2017
Clinical FDA rare diseases Researches
7th Annual Congress on Clinical Microbiology

End Date: Tuesday, 26 September, 2017 5:00pm Clinical Microbiology 2017 is a premier forum to evaluate latest innovations in the field of Clinical Microbiology and Microbial Genomics. Clinical Microbiology-2017 graciously solicits the presence of presenters, speakers, students, and exhibitors from all over the world to Chicago, Illinois, USA on September 25th-26th, 2017.
- Source: conferenceseries.com
- 678
- September 21, 2017
Clinical Exhibitions & Activities Microbiology
FDA grants fast-track designation for Shire’s lung drug

The FDA has granted Fast Track designation to Shire's SHP607 for the prevention of chronic lung disease in extremely premature infants.
- Source: Pharmatimes
- 584
- September 14, 2017
chronic Clinical lung New Approvals
LabCorp completes $1.2B Chiltern buy

Diagnostics company LabCorp (NYSE:LH) said today that it has closed its $1.2 billion acquisition of contract research organization Chiltern International.
- Source: drugdeliverybusiness
- 667
- September 4, 2017
acquisition Clinical Market Views oncology
Merck sees promise in Macrophage Pharma

Merck Ventures has become the latest group to invest in Macrophage Pharma and take a position on the UK biotech’s board of directors.
- Source: pharmatimes
- 636
- August 25, 2017
Clinical Market Views Merck

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.